Navigation Links
Greater Baltimore Committee to Announce Winners of Third Baltimore Region Bioscience Awards at Ceremonies on March 18
Date:3/17/2008

BALTIMORE, March 17 /PRNewswire-USNewswire/ -- The following was issued today by the Greater Baltimore Committee:

WHO:

Donald C. Fry, president & CEO, Greater Baltimore Committee

140 company owners, executives and researchers from the Baltimore-area bioscience community

WHAT:

The third annual Greater Baltimore Region Bioscience Awards

WHEN:

Tuesday, March 18, 2008

8:00 a.m. / Breakfast & Registration

8:45 - 9:30 a.m. / Awards Program

WHERE:

Renaissance Harborplace Hotel, 202 East Pratt Street, Baltimore, MD 21202

DETAILS:

More than 140 leaders from the Baltimore region's bioscience industry and research community will attend a breakfast reception at the Greater Baltimore Committee to honor winners of the 2008 Greater Baltimore Region Bioscience Awards.

This is the third annual awards event presented by the Greater Baltimore Committee, the region's most prominent organization of business and civic leaders, to recognize outstanding achievements in the region's bioscience industry. The Greater Baltimore Committee has made support for the emerging bioscience industry in the region one of its top long-term priorities.

Award winners, to be announced, were selected from among 22 nominations submitted by businesses, bioscience advocates, higher education institutions and government officials.

Awards will be presented in the following categories: Best New Product or Progress Award, Entrepreneurship Award, Leadership in Bioscience Award, and President's Award.

Nominees for this year's awards are:

Best New Product or Progress Award

-- Kris Appel, President & CEO, Encore Path, Inc.

-- Timothy E. Askew, President & CEO, CSA Medical, Inc.

-- James Campbell, M.D., CEO, Arcion Therapeutics

-- William G. Hearl, Ph.D., Founder & President, Immunomic Therapeutics, Inc.

-- Ryan Sysko, Founder & CEO, WellDoc Communications, Inc.

Entrepreneurship Award

-- Mohamed S. Al-Ibrahim, MB ChB, FACP, COO & President, SNBL Clinical Pharmacology Center, Inc.

-- Scott Allocco, President, BioMarker Strategies, LLC

-- Atul Bedi, M.D., Founder, President & Chief Executive Officer, IATRICa Inc.

-- David S. Block, Founder & CEO, Gliknik, Inc.

-- Julie D. Suman, R.Ph., Ph.D., Co-founder & President, Next Breath, LLC

-- Reza Mazhari, Ph.D., VP, Research & Pharmacology and Peter Suzdak, Ph.D.,President/CEO & Co-founder, Cardioxyl Pharmaceuticals, Inc.

-- Jian Wang, Ph.D., President & CEO, BioFortis

Leadership in Bioscience Award

-- Drew M. Pardoll, M.D., Ph.D., Amplimmune

-- Blake M. Paterson, M.D., CEO and Co-founder, Alba Therapeutics Corporation

President's Award

-- Stephen P. Auvil, Co-PI, Director, Office of Technology Development, UMBC and the ACTiVATE Program

-- Delegate Dan K. Morhaim, M.D., The Maryland House of Delegates, 11th District, Baltimore County

-- David J. Ramsay, DM, DPhil, President, University of Maryland, Baltimore

-- John T. (Jack) Shannon, Jr., President and CEO, East Baltimore Development Inc. and Scott Levitan, Senior Vice President, Development Director, Forest City Science + Technology Group, Forest City - New East Baltimore Partnership

-- Paul Silber, Former President/CEO & Founder, InVitro Technologies, Inc.

-- Kathleen O'Donnell Weiss, Executive Director, The BioTechnical Institute of Maryland, Inc.

Program sponsor for the event is KAWG&F. Media sponsor is The Daily Record.

To attend and cover this event, contact: Diane Hughes, 410-727-2820, x32


'/>"/>
SOURCE Greater Baltimore Committee
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
2. University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
3. New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
4. GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral)
5. Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair
6. California Stem Cell Board Member Violates Conflict Rules; Should Resign From Committee, Consumer Group Says
7. Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings
8. California IVF Experts Tap Ethics Committee for Guidance
9. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
10. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
11. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
Breaking Biology Technology:
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
(Date:3/21/2016)... Unique technology combines v ... security   Xura, Inc. ... digital communications services, today announced it is working alongside ... customers, particularly those in the Financial Services Sector, the ... within a mobile app, alongside, and in combination with, ...
Breaking Biology News(10 mins):